Predible Health vs Qure.ai
In-depth comparison — valuation, funding, investors, founders & more
🇮🇳 India · Sanjoy Paul
Valuation
N/A
Total Funding
$5M
10-50 employees
🇮🇳 India · Prashant Warier
Valuation
$270M
Total Funding
$157M
250 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Predible Health and Qure.ai compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation. Qure.
Qure.ai carries a known valuation of $270M, while Predible Health's valuation has not been publicly disclosed. On the funding side, Qure.ai has raised $157M in total — $152M more than Predible Health's $5M.
Qure.ai has 1 year more market experience, having been founded in 2016 compared to Predible Health's 2017 founding. In terms of growth stage, Predible Health is at Series A while Qure.ai is at Series D — a meaningful difference for investors evaluating risk and upside.
Both companies are headquartered in 🇮🇳 India, competing for the same regional talent and customer base. On Awaira's 0–100 composite score, Qure.ai leads with a score of 70, reflecting stronger overall fundamentals across valuation, funding, and growth signals.
Metrics Comparison
| Metric | Predible Health | Qure.ai |
|---|---|---|
💰Valuation | N/A | $270M |
📈Total Funding | $5M | $157MWINS |
📅Founded | 2017WINS | 2016 |
🚀Stage | Series A | Series D |
👥Employees | 10-50 | 250 |
🌍Country | India | India |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 50 | 70WINS |
Key Differences
Funding gap: Qure.ai has raised $152M more ($157M vs $5M)
Market experience: Qure.ai has 1 year more (founded 2016 vs 2017)
Growth stage: Predible Health is at Series A vs Qure.ai at Series D
Team size: Predible Health has 10-50 employees vs Qure.ai's 250
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Qure.ai scores 70/100 vs Predible Health's 50/100
Which Should You Choose?
Use these signals to make the right call
Choose Predible Health if…
- ✓Predible Health develops AI software for radiology and medical imaging analysis, with a focus on automated CT scan interpretation for lung nodule detection, COVID-19 assessment, and liver segmentation
Choose Qure.ai if…
Top Pick- ✓Higher Awaira Score — 70/100 vs 50/100
- ✓More established by valuation ($270M)
- ✓Stronger investor backing — raised $157M
- ✓More market experience — founded in 2016
- ✓Qure
Funding History
Predible Health raised $5M across 0 rounds. Qure.ai raised $157M across 5 rounds.
Predible Health
No public funding data available.
Qure.ai
Series D
Jan 2021
Series C
Jan 2020
Series B
Jan 2018
Series A
Jan 2017
Lead: Accel Partners
Seed
Jan 2016
Investor Comparison
No shared investors detected between these two companies.
Unique to Qure.ai